Literature DB >> 32317120

HCV-Infected Deceased Donor Kidney Transplantation-Time to Take Up the Offer.

Yuvaram N V Reddy1, Krishna P Reddy2, Meghan E Sise3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32317120      PMCID： PMC7247921          DOI： 10.1053/j.ajkd.2020.01.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  14 in total

1.  Transplanting Hepatitis C-Positive Kidneys.

Authors:  Peter P Reese; Peter L Abt; Emily A Blumberg; David S Goldberg
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

2.  Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010-2016.

Authors:  Donald F Chute; Meghan E Sise
Journal:  Am J Nephrol       Date:  2018-02-13       Impact factor: 3.754

Review 3.  Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.

Authors:  Donald F Chute; Raymond T Chung; Meghan E Sise
Journal:  Kidney Int       Date:  2018-01-09       Impact factor: 10.612

4.  National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.

Authors:  Vishnu S Potluri; David S Goldberg; Sumit Mohan; Roy D Bloom; Deirdre Sawinski; Peter L Abt; Emily A Blumberg; Chirag R Parikh; James Sharpe; K Rajender Reddy; Miklos Z Molnar; Meghan Sise; Peter P Reese
Journal:  J Am Soc Nephrol       Date:  2019-09-12       Impact factor: 10.121

5.  Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.

Authors:  Mary G Bowring; Ashton A Shaffer; Allan B Massie; Andrew Cameron; Niraj Desai; Mark Sulkowski; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Am J Transplant       Date:  2019-04-09       Impact factor: 8.086

6.  Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.

Authors:  Peter P Reese; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Roy D Bloom; Vishnu S Potluri; Matthew Levine; Paige Porrett; Deirdre Sawinski; Susanna M Nazarian; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Caren Gentile; Jennifer Smith; Bijan A Niknam; Melissa Bleicher; K Rajender Reddy; David S Goldberg
Journal:  Ann Intern Med       Date:  2018-08-07       Impact factor: 25.391

7.  Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.

Authors:  Mark H Eckman; E Steve Woodle; Charuhas V Thakar; Rita R Alloway; Kenneth E Sherman
Journal:  Am J Kidney Dis       Date:  2020-02-17       Impact factor: 8.860

8.  Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.

Authors:  Nikhil Kapila; K V Narayanan Menon; Kawtar Al-Khalloufi; Jason M Vanatta; Carla Murgas; Diego Reino; Samer Ebaid; Joshua J Shaw; Neerja Agrawal; Salwa Rhazouani; Viviana Navas; Cedric Sheffield; Asad Ur Rahman; Michael Castillo; Christina C Lindenmeyer; Charles Miller; Cristiano Quintini; Xaralambos B Zervos
Journal:  Hepatology       Date:  2020-04-15       Impact factor: 17.425

9.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598

10.  Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.

Authors:  Victor de Lédinghen; Claire Laforest; Christophe Hézode; Stanislas Pol; Alain Renault; Laurent Alric; Dominique Larrey; Sophie Métivier; Albert Tran; Caroline Jézéquel; Didier Samuel; Fabien Zoulim; Christelle Tual; Aurélie Pailhé; Séverine Gibowski; Marc Bourlière; Eric Bellissant; Jean-Michel Pawlotsky
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 20.999
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.